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Pancreatic endocrine cell differentiation is orchestrated by the action of transcription factors that op-
erate in a gene regulatory network to activate endocrine lineage genes and repress lineage-inappro-
priate genes. MicroRNAs (miRNAs) are important modulators of gene expression, yet their role in
endocrine cell differentiation has not been systematically explored. Here we characterize miRNA-reg-
ulatory networks active in human endocrine cell differentiation by combining small RNA sequencing,
miRNA over-expression, and network modeling approaches. Our analysis identified Let-7g, Let-7a,
miR-200a, miR-127, and miR-375 as endocrine-enriched miRNAs that drive endocrine cell differentia-
tion-associated gene expression changes. These miRNAs are predicted to target different transcrip-
tion factors, which converge on genes involved in cell cycle regulation. When expressed in human em-
bryonic stem cell-derived pancreatic progenitors, these miRNAs induce cell cycle exit and promote
endocrine cell differentiation. Our study delineates the role of miRNAs in human endocrine cell differ-
entiation and identifies miRNAs that could facilitate endocrine cell reprogramming.
INTRODUCTION
The potential to generate pancreatic beta cells from human pluripotent stem cells (hPSCs) or via cell re-
programming from other cell sources holds promise for modeling causes of diabetes and cell replacement
therapies (Benthuysen et al., 2016). Knowledge of the molecular underpinnings of pancreas and beta cell
development has enabled some success in developing beta cell reprogramming and directed differentia-
tion strategies. In particular, the identification of transcription factors (TFs) governing cell fate decisions has
been instrumental for cell reprogramming approaches (Benthuysen et al., 2016). Although TFs play a major
role in orchestrating gene expression changes during developmental transitions, recent evidence also
shows significant roles for other regulators such as small RNAs.
MicroRNAs (miRNAs) are a group of small non-coding RNAs (22 nucleotides) with known roles in the regu-
lation of gene expression in development, mature cell function, and disease (Vidigal and Ventura, 2015).
Studies in mice and zebrafish have demonstrated important roles for miRNAs in pancreatic endocrine
cell development and beta cell function (Kaspi et al., 2014). Pancreatic progenitor cell-specific deletion
ofDicer1, an enzyme that is universally required for the functional maturation of miRNAs, results in reduced
endocrine cell numbers (Lynn et al., 2007), whereasDicer1 disruption in beta cells impairs insulin biogenesis
(Melkman-Zehavi et al., 2011). At the level of individual miRNAs, miR-375 (Kloosterman et al., 2007; Poy
et al., 2009) and miR-7 (Kredo-Russo et al., 2012; Latreille et al., 2014) have been identified as regulators
of beta cell differentiation and function.
Generally, miRNAs are thought to repress target mRNAs and act by destabilizing mRNAs through base
pairing between the miRNA seed sequence (nucleotides at position 2–8) and a complementary sequence
in the target mRNA (Guo et al., 2010; Lim et al., 2005). However, recent evidence suggests that miRNAs can
also activate gene expression (Jopling et al., 2008; Valinezhad Orang et al., 2014; Vasudevan et al., 2007).
The effects of individual miRNAs on gene expression are generally small, which has led to the concept that
miRNAs fine-tune gene expression rather than acting as genetic switches (Vidigal and Ventura, 2015).
Consistent with this idea, miRNAs have been shown to promote cell differentiation and to facilitate cell re-
programming when force expressed in conjunction with lineage-determining TFs (Chen et al., 2004, 2006;iScience 21, 681–694, November 22, 2019 ª 2019 The Authors.
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Dey et al., 2012; Lim et al., 2005; Nam et al., 2013; Yoo et al., 2011). Mechanistically, each miRNA has the
ability to repress hundreds of mRNA targets, and multiple miRNAs often converge on a single pathway
to promote a common developmental outcome (Lim et al., 2005; Vidigal and Ventura, 2015). Therefore,
a comprehensive understanding of context-specific contributions of miRNAs to gene regulation requires
a systems-level approach where all miRNAs and their targets are considered.
In this study we used genome-wide small RNA sequencing to identify candidate miRNAs with possible
roles in human endocrine cell differentiation. By comparing miRNA profiles of hPSC-derived pancreatic
progenitors and human cadaveric beta and alpha cells genome-wide, we identified miRNAs that are
induced during endocrine cell differentiation. Through gain-of-function experiments during hPSC differen-
tiation, we show that islet cell-enriched miRNAs act to promote cell cycle exit and hence islet cell differen-
tiation. Integrating RNA-seq, CLIP-seq, and chromatin state data, we applied a network modeling
approach to identify candidate miRNA-regulated TFs that explain the impact of islet cell-enriched miRNAs
on cell cycle regulation during endocrine cell differentiation. Our findings provide a systems-level view of
how miRNAs regulate human endocrine cell differentiation, which has implications for programming islet
endocrine cells from hPSCs or other cell sources.
RESULTS
Identification of miRNAs Up-Regulated during Endocrine Cell Differentiation
To identify miRNAs that are regulated during pancreatic beta cell differentiation, we conducted
genome-wide small RNA sequencing in pancreatic progenitor cells derived from CyT49 human embry-
onic stem cells (hESCs) (Figure S1) and primary beta cells isolated from cadaveric human islets by fluo-
rescence-activated cell sorting (Kameswaran et al., 2014) (Figure 1A). Although both up- and down-regu-
lated miRNAs could have roles in beta cell differentiation, we here focused on miRNAs that increase in
expression during endocrine cell differentiation. By comparing expression levels of individual miRNAs in
beta cells and pancreatic endoderm stage (PE) cells, we defined miRNAs induced during beta cell differ-
entiation. This analysis revealed 14 miRNAs that were more highly expressed in beta cells than in PE cells
(>5,000 sequence reads in beta cells; > 2.3-fold increase; Figure 1B and Tables S1A and S1B). With the
exception of miR-127, miR-204, and miR-99b, the same miRNAs also exhibited higher expression in
sorted alpha cells compared with PE cells (Figure 1C and Tables S1A and S1C), suggesting shared roles
for most miRNAs in the development of both endocrine cell types. Among the miRNAs induced during
endocrine cell differentiation were miR-375, miR-200a/c, and miR-7, which have reported roles in beta
cell development, proliferation, function, and survival in mice (Belgardt et al., 2015; Kloosterman
et al., 2007; Kredo-Russo et al., 2012; Latreille et al., 2014; Nieto et al., 2012; Poy et al., 2004, 2009;
Wang et al., 2013). Most notable was the significantly higher expression of members of the Let-7 miRNA
family in both beta and alpha cells compared with PE cells, including Let-7a, Let-7b, Let-7f, Let-7g, and
miR-98 (Figures 1B and 1D and Tables S1A and S1B). We confirmed the results from the small RNA
sequencing by comparing miRNA levels in PE cells and human cadaveric islets using the Taqman miRNA
assay (Figure 1E).
Identifying miRNAs Regulating Human Endocrine Cell Differentiation
To identify mRNAs regulated by these miRNAs, we selected several miRNAs for over-expression in hESC-
derived PE cells. We included the top three beta cell-enriched miRNAs (miR-375, miR-127, and Let-7a), as
well as Let-7g andmiR-200a, as they are highly induced during endocrine cell differentiation. miR-7 was not
included because of its inhibitory role in endocrine cell differentiation in mice (Kredo-Russo et al., 2012).
To determine the effects of these miRNAs on gene expression, we next over-expressed Let-7g, Let-7a,
miR-200a, miR-375, and miR-127 individually in hESC-derived PE cells (Figure 2A). For these studies, we
chose PE cells derived from H1 hESCs because a recently published protocol showed very efficient dif-
ferentiation of H1 hESCs into beta-like cells in vitro (Rezania et al., 2014). Since our genome-wide small
RNA sequencing was performed in PE cells from CyT49 hESCs (Figure 1), we first confirmed that H1 and
CyT49 hESC-derived PE cells have similar molecular features. Similar to CyT49 hESC-derived PE cells
(Figure S1), 98% of H1 hESC-derived PE cells expressed the pancreatic progenitor marker PDX1 (Figures
S2A and S2B). In addition, RNA-seq analysis showed highly concordant transcriptome profiles of H1 and
CyT49 hESC-derived PE cells [(R) > 0.92; Figure S2C]. Furthermore, we confirmed that Let-7g, Let-7a,
miR-200a, and miR-375 were expressed at similarly low levels in H1 and CyT49 hESC-derived PE cells
(Figure S2D).682 iScience 21, 681–694, November 22, 2019
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Figure 1. Identification of miRNAs Up-Regulated during Endocrine Cell Differentiation of Human Pancreatic
Progenitor Cells
(A) Workflow for genome-wide small RNA profiling of pancreatic progenitors (pancreatic endoderm, PE) and endocrine
islet cells. PE cells were differentiated from human embryonic stem cells (hESCs), and human alpha and beta cells were
isolated from cadaveric human islets by fluorescence-activated cell sorting (FACS).
(B and C) MA plots comparingmiRNA expression levels in PE cells and beta cells (B) or PE cells and alpha cells (C). miRNAs
with higher expression in beta and alpha cells than PE are indicated by red circles in B and C, respectively. Blue lines
indicate 2-fold change in miRNA expression; yellow line indicates no change.
(D) Heatmap comparing expression levels in PE, alpha cells, and beta cells of the thirteen most highly enriched miRNAs in
beta cells compared with PE cells.
(E) Relative expression of indicated miRNAs determined by Taqman qPCR in PE cells and human islets.
Data are shown as meanG S.E.M. (n = 3 biological replicates). ns, not significant; **p < 0.01, ***p < 0.001; Student’s t test.
See also Figure S1 and Table S1.
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Figure 2. Endocrine Cell-EnrichedmiRNAs Regulate Expression of Cell Cycle Genes in Pancreatic Progenitor Cells
(A) Workflow to identify genes repressed by each indicated miRNA after lentiviral transduction of hESC-derived
pancreatic endoderm (PE) cells. Transduced cells were sorted based on mCherry after 48 h, RNA-seq analysis performed
(n = 3 biological replicates), and down-regulated genes identified.
(B–F) Venn diagrams showing the overlap between genes down-regulated in islets (n = 3) compared with PE (n = 2) (blue)
and genes repressed by Let-7g (purple, B), Let-7a (red, C), miR-200a (yellow, D), miR-375 (green, E), or miR-127 (light blue,
F). Top five GO categories enriched among genes repressed by the miRNA and down-regulated in islets compared with
PE are shown on the right.
(G) Venn diagram showing overlap between miRNA-repressed genes.
See also Figure S2, Tables S2, and S3.
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Inclusion of an mCherry reporter into the miRNA constructs allowed us to monitor transduction efficiencies
in PE stage cultures and to isolate transduced cells by FACS. We observed 13%–20% mCherry+ PE cells
2 days after transduction, and this number increased to 34%–49% 6 days after transduction (Figure S2E).
The increase is likely explained by the lentiviral expression vector requiring more than 2 days to reach
maximum expression. To identify miRNA targets, we analyzed sorted mCherry+ PE cells 2 days after trans-
duction, reasoning that this early time point is best suited for studying the direct effects of miRNA on gene
expression. As expected, Let-7g, Let-7a, miR-200a, miR-375, and miR-127 were each expressed at signifi-
cantly higher levels in cells transduced with the miRNA-expressing vector compared with control vector-
transduced cells (Figure S2F). Furthermore, forced expression of Let-7g, Let-7a, miR-200a, miR-375, or
miR-127 in hESC-derived PE repressed the expression of genes (p < 0.05, permutation test, Tables S2A–
S2E) that were down-regulated between PE and islets (Figure S2G), suggesting that these miRNAs could
contribute to gene expression changes during islet cell differentiation.
Islet Cell-Enriched miRNAs Regulate Expression of Cell Cycle Genes in Pancreatic Progenitor
Cells
To identify miRNA-regulated transcripts with likely roles in endocrine cell differentiation, we analyzed sets
of genes that were down-regulated by forced expression of each miRNA (p < 0.05, permutation test) and
also down-regulated in islets as compared with PE cells (p < 0.05, permutation test, Figures 2B–2F). These
mRNA subsets comprised 16.5% of Let-7g-, 13.9% of Let-7a-, 18.5% of miR-200a-, 18.7% of miR-375-, and
30.3% of miR-127-repressedmRNAs in PE cells. We then performed Gene Ontology (GO) analysis to define
the biological processes regulated by mRNAs that are repressed by individual miRNAs and are also ex-
pressed at lower level in islet than PE cells. The top five enriched GO categories for each one of these
miRNA-regulated sets of mRNAs comprised processes associated with DNA replication and regulation
of the cell cycle (Figures 2B–2F and Tables S3A–S3E). Given that endocrine cell formation is associated
with cell cycle exit (Kim et al., 2015; Miyatsuka et al., 2011; Piccand et al., 2014), these findings suggest
that miRNAs could control endocrine cell differentiation by regulatingmRNAs involved in cell cycle control.
The finding that all five miRNAs regulate cell cycle-associated transcripts raised the question of whether
they share similar target genes. Analysis of the extent of overlap between the mRNAs down-regulated
by Let-7g, Let-7a,miR-200a,miR-375, andmiR-127 revealed amodest number of shared targets (Figure 2G).
Only seven mRNAs (ZNF239, PIF1, CDC45, TMEM114, HIST1H4H, MRPS25, and ESPL1) were repressed by
all fivemiRNAs, indicating distinct regulatory roles for each one of themiRNAs. Together, these results sug-
gest distinct but converging miRNA targets in regulating cell division in pancreatic progenitors.
Since all candidate miRNAs appeared to regulate different aspects of cell cycle progression, we sought to
gain further insight into how input from the different miRNAs converges on cell cycle regulation. To study
the combined effect of miRNAs, we generated a ‘‘polycistronic’’ miRNA (poly-miR) lentiviral construct that
drives the expression of Let-7g, Let-7a, miR-200a, and miR-375 under the control of a single promoter.
miR-127 was excluded because overall it repressed fewer genes than the other miRNAs (Figure 2F). We ex-
pressed the poly-miR construct in H1 hESC-derived PE cells and analyzed the transcriptome two days after
transduction (Figure 3A). miRNA expression analysis in mCherry-sorted cells revealed that Let-7g, Let-7a,
miR-200a, and miR-375 were each significantly higher expressed in poly-miR- than vector-only-transduced
PE cells (Figures S3A and S3B). Expression of the poly-miR construct in PE cells resulted in down-regulation
of 2,463 transcripts (p < 0.05; permutation test). Consistent with the results from expression of individual
miRNAs (Figure S2G), poly-miR-repressed mRNAs (p < 0.05, permutation test, Table S2F) were highly en-
riched for mRNAs with higher expression in PE compared with islets (Figure S3C and Table S2G). Of the
2,463 poly-miR-repressed mRNAs, 388 were also down-regulated during the transition of PE to islet (Fig-
ure S3D). As predicted, genes involved in cell cycle processes were overrepresented among these 388
mRNAs (Figure S3D and Table S3F).
Endocrine-Enriched miRNAs Regulate Cell Cycle-Associated Transcription Factors
To decipher mechanisms by which Let-7g, Let-7a, miR-200a, and miR-375 regulate cell cycle genes, we
sought to distinguish direct and indirect targets of the four miRNAs (Figure 3A). We defined putative direct
targets as poly-miR-repressedmRNAs (p < 0.05, permutation test, Table S2F) predicted to be direct targets
by TargetScan (based on matching sequence to the miRNA seed region) and/or exhibiting binding to the
RNA-binding protein Argonaute, as determined by CLIP-seq in human islets (Kameswaran et al., 2014).
From this analysis, 223 putative direct target mRNAs were identified (Figure 3B and Table S4A). Of
these, all were predicted by TargetScan and 35 also by HITS-CLIP. These 223 genes represent 9.1% ofiScience 21, 681–694, November 22, 2019 685
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Figure 3. Identification of Putative Direct miRNA Target mRNAs in Pancreatic Progenitor Cells
(A) Workflow to identify repressed genes after transduction of hESC-derived pancreatic endoderm (PE) cells with a
lentivirus expressing a polycistronic construct for the indicated miRNAs (poly-miR) and mCherry. Transduced cells were
sorted after 48 h, RNA-seq analysis performed (n = 3 biological replicates), and down-regulated genes identified. Direct
targets of candidate miRNAs were identified based on TargetScan and CLIP-seq analysis.
(B) Pie graph showing percentage of direct (dark gray) and indirect (light gray) targets of candidate miRNAs repressed by
poly-miR construct.
(C) GSEA plot showing enrichment of 223 direct target genes of Let-7g, Let-7a, miR-200a, and miR-375 in islets (n = 3)
compared with PE (n = 2). False Discovery Rate (FDR) is shown.
(D) mRNA expression levels of transcription factors directly targeted by Let-7g, Let-7a, miR-200a, and miR-375 measured
in reads per kilobase per million reads mapped (RPKM).
(E) Predicted network of transcription factors downstream of miRNAs. Transcription factors are indicated by gray
triangles, and individual miRNAs are indicated by colored squares.
See also Figure S3, Tables S2, S3, and S4.
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all poly-miR-repressed genes. Reinforcing the potential relevance of these predicted direct miRNA targets
for endocrine cell development, GSEA analysis showed significantly lower expression of these genes in is-
lets than in PE cells (Figure 3C).
To determine whether miRNAs are direct regulators of cell cycle-associated mRNAs in PE cells, we
analyzed enriched GO terms among the 223 predicted direct miRNA targets. We found no enrichment
of categories linked to cell cycle-related processes (Table S4B). Moreover, many of the cell cycle regulators
that were repressed by the poly-miR, including CCND3, CDC45,MCM7, and CKS1B (Table S2F), were not
among the predicted direct miRNA targets (Table S4A). Thus, cell cycle-associated transcripts appear to be
indirectly regulated by the miRNAs. We postulated that this indirect effect of miRNAs on the expression of
cell cycle genes could be mediated through the regulation of TFs. Consistent with this hypothesis, 21 TFs
were among the 223 putative direct miRNA targets (Figure 3D and Tables S4A and S4C). A striking finding
was that many of these TFs have documented roles in cell cycle regulation, including E2F2, which is part of
the complex controlling cell cycle progression, and numerous TFs are known to regulate cell growth (e.g.,
ZC3H10, ZNF783, ZBTB46, ZBTB5, ZFYVE26, TP53, EZH1, HIF3A, DPF2, TEAD3). In addition, TFs predicted
to be directly regulated by the miRNAs included TFs involved in the regulation of endocrine cell develop-
ment and maturation, such as NKX6.1 (Schaffer et al., 2013; Taylor et al., 2013) and the thyroid hormone
receptor THRA, consistent with the role of thyroid hormone in beta cell maturation (Matsuda et al.,
2017). Reflective of their shared seed sequence, TFs that are predicted to be directly regulated by Let-
7g and Let-7a showed complete overlap, whereas miR-200a and miR-375 mostly regulated separate sets
of TFs (Figure 3E). This analysis indicates that Let-7g, Let-7a, miR-200a, and miR-375 might jointly change
the transcriptional landscape in PE cells by down-regulating expression of different sets of TFs.miRNAs Regulate a Network of Cell Cycle Genes in Pancreatic Progenitor Cells
Having identified a set of TFs as potential direct miRNA targets, we next sought to determine whether
these TFs could act downstream of the miRNAs to regulate cell cycle genes. To test this, we constructed
and subsequently probed a miRNA-gene regulatory network, linking the four candidate miRNAs and their
putative direct TF targets to poly-miR-regulated genes predicted to be target genes of the TFs (Figures 4A,
S4A, and S4B). First, to identify TF-binding events close to poly-miR-regulated genes (down- and up-regu-
lated), we used ATAC-seq data from PE cells and islets and mapped open chromatin regions surrounding
transcriptional start sites (TSSs; closest within 10 kb) of these genes (n = 241,922 sites; FDR <0.01, MACS2)
(Figures 4A and S4A; see Transparent Methods). Second, to pinpoint identified candidate TF-bound re-
gions with likely impact on gene regulation during the PE to islet transition, we identified ATAC sites ex-
hibiting dynamics in histone modifications between PE cells and islets. We focused on H3K4me3 and
H3K27ac, two highly dynamic histone modifications during development (Wang et al., 2015; Xie et al.,
2013) that have been associated with active promoters (H3K4me3) and active promoters and enhancers
(H3K27ac) (Creyghton et al., 2010; Heintzman et al., 2009). We then tested whether changes in these histone
marks are accompanied by expression changes of proximal genes. As predicted, an increase in
H3K4me3 and H3K27ac deposition in PE compared with islets was associated with higher mRNA levels
(p = 5.3 3 10134; Mann-Whitney test), whereas a decrease was associated with lower mRNA levels
(p = 1.93 1036). Finally, to construct the network, we linked open chromatin regions with dynamic histone
marks to miRNA-regulated TFs by identifying those regions with a matching TF-binding motif. Validating
our miRNA-gene regulatory network, GO analysis showed that the 1,307 genes comprising the network
were enriched for cell cycle regulators (Figure S4C and Table S5).
Having validated our approach of linking putative TF binding events to changes in gene transcription dur-
ing the PE to islet transition, we next assembled all data into a structured graph (Figures 4A and S4A)
consisting of different types of nodes that represent the individual datasets, namely, the four candidate
miRNAs (squares, Let-7g, Let-7a, miR-200a, and miR-375), their predicted target TFs (triangles), predicted
TF-binding regions (hexagons), and indirect miRNA target genes (circles). Each connection between nodes
(i.e., edge) was given a score representing the strength of their association, as inferred from miRNA-target
databases (a), from algorithms matching TF motifs to DNA sequences (b), or from differential regulation of
the connected gene (c) (see Figure S4A for details). A combined score was then computed for each possible
path in the network from a miRNA to a gene. The score for an individual gene (G1) regulated by a miRNA is
the sum of the edge scores (S1 = a1 + b1 + c1). To account for effects of more than one miRNA on an in-
dividual gene, we then computed a combined score representing the connectivity of the four miRNAs to
G1. According to this scoring system, a higher rank is assigned to genes with strong connectivity ofiScience 21, 681–694, November 22, 2019 687
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genes. Building of network (left) and probing of network (right) is summarized. The nodes of the graph represent miRNAs
(squares; Let-7g [purple], Let-7a [red], miR-200a [yellow], and miR-375 [green]), TFs (triangles), TF-binding regions
(hexagons), and genes (circles).
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See also Figure S4, Tables S5, and S6.individual miRNA-mediated paths and characterized by an effect of more than one miRNA (Figure S4B and
Table S6). The resulting network of the 40 highest scoring cell cycle genes demonstrates direct connectivity
of the four miRNAs with cell cycle regulators through several TFs, including SOX12, RFX1, TP53, E2F2,
MBD2, ZNF512B, ZNF783, and ZNF641 (Figure 4B). Of interest is the identification of NEUROD1 as an in-
direct miRNA target of Let-7 miRNAs and miR200a. Neurod1 is a TF that has been shown to induce cell cy-
cle exit and to regulate endocrine cell differentiation in model organisms (Ahnfelt-Ronne et al., 2007; Mu-
toh et al., 1998). Our network analysis identifies a core network of miRNAs, TFs as their putative direct
targets, and down-stream genes with likely roles in cell cycle regulation and endocrine cell differentiation.688 iScience 21, 681–694, November 22, 2019
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Figure 5. Endocrine Cell-Enriched miRNAs Regulate Cell Cycle Exit and Endocrine Cell Differentiation
(A) Workflow to test effects of miRNAs on cell proliferation and endocrine cell differentiation during the transition of
hESC-derived pancreatic endoderm (PE) to the early endocrine (EN) cell stage. Early PE stage cells were transduced with a
lentivirus expressing a polycistronic construct for the indicated miRNAs (poly-miR) and mCherry, cultured in 2D until the
end of the PE stage, aggregated, differentiated in 3D to the EN stage, sectioned, and stained for Ki-67 and insulin (INS).
(B) Representative images showing immunofluorescence staining for Ki-67 (left) and INS (right) together with mCherry and
DAPI at the EN stage for control vector (top) or poly-miR (bottom) transduced aggregates. Scale bar, 50 mm.
(C and D) Percentage of Ki-67+ cells (C) and INS+ cells (D) in the mCherry+ cell population. Data are shown as
mean G S.E.M. (n = 3 biological replicates, each dot represents cell counts in a single aggregate from one of three
independent experiments).
(E and F) Cells were sorted based on mCherry at the EN stage, RNA-seq analysis performed (n = 4 biological replicates),
and differentially expressed genes in control and poly-miR transduced cells identified. Enriched GO categories (top) and
log2-fold change (FC) of exemplary genes (bottom) among genes down- (E, p < 0.05, permutation test) and up-regulated
(F, p < 0.05, permutation test) by the poly-miR. *p < 0.05, Student’s t test.
See also Figure S5 and Table S7.miRNAs Regulate Endocrine Cell Differentiation by Promoting Cell Cycle Exit
We next determined whether forced expression of Let-7g, Let-7a, miR-200a, and miR-375 represses cell cy-
cle progression in hESC-derived pancreatic progenitor cells, as predicted by our computational analysis.
We transduced PE cells with the poly-miR lentiviral construct and differentiated these cells for another
6 days as 3D aggregates to the early pancreatic endocrine (EN) stage, when insulin+ cells are first present
(Figure 5A). Sectioned aggregates were then stained for the proliferation marker Ki-67. Consistent with our
computational prediction, forced expression of the miRNAs reduced the percentage of Ki-67+ cells (Fig-
ures 5B and 5C). The miRNAs likely exhibit their anti-proliferative effect in progenitors and not beta cells,
as insulin+ cells in EN stage cultures were mostly Ki67 in both control vector- and poly-miR-transduced
aggregates (Figure S5A).
Since cell cycle exit and endocrine cell differentiation are tightly coupled (Kim et al., 2015; Miyatsuka et al.,
2011; Piccand et al., 2014), we tested whether the reduction in Ki-67+ cells after miRNA over-expression was
associated with an increase in the number of insulin+ cells. Indeed, we observed a higher percentage of
insulin+ cells in aggregates expressing the poly-miR construct compared with vector-transduced aggre-
gates (Figures 5B and 5D). The bias of our culture conditions for the differentiation of insulin+ cells (Fig-
ure S5B) precluded quantification of other endocrine cell types. To further determine how Let-7g, Let-
7a, miR-200a, and miR-375 over-expression affects gene expression at the EN stage, we conducted
RNA-seq analysis of sorted mCherry+ cells. Consistent with the reduction in Ki67+ cells in poly-miR-trans-
duced cultures (Figure 5C), genes associated with cell cycle regulation, such as CCND1, CDK4, and PCNA,
were enriched among genes down-regulated (p < 0.05, permutation test) by forcedmiRNA expression (Fig-
ure 5E and Tables S7A and S7B). Up-regulated genes (p < 0.05, permutation test) comprised endocrine
cell-characteristic genes involved in the regulation of insulin secretion and ion transport (e.g., GLPR1,
SYT1, CACNA1A, SLC2A1) (Figure 5F and Tables S7A and S7C), further supporting the conclusion that
Let-7g, Let-7a, miR-200a, and miR-375 promote endocrine cell differentiation. We note that insulin
mRNA levels were slightly decreased rather than increased in poly-miR transduced cells (Table S7A), sug-
gesting that miRNAs or their target genes could affect insulin protein levels at the posttranscriptional level.
Taken together, our data support a model whereby endocrine-enriched Let-7g, Let-7a, miR-200a, andmiR-
375 are part of a gene regulatory network that triggers cell cycle exit to promote endocrine cell
differentiation.DISCUSSION
Here, we identified 14 miRNAs (Let-7g, Let-7a, Let-7f, Let-7b, miR-200a, miR-200c, miR-204, miR-99b, miR-
141, miR-127, miR-7, miR-27b, miR-98, and miR-375), that are induced during human beta cell differentia-
tion. We further studied five miRNAs (Let-7g, Let-7a, miR-200a, miR-375, and miR-127) with a high fold-
change during endocrine cell differentiation and experimentally show that these miRNAs induce cell cycle
exit in pancreatic progenitor cells. By constructing an integrated miRNA-gene regulatory network of endo-
crine cell differentiation, we show that these miRNAs likely contribute to endocrine cell differentiation by
directly regulating different sets of cell cycle-associated TFs.
To analyze how islet cell-enriched miRNAs cooperate to drive endocrine cell differentiation, we developed
a computational method to model the relationship of miRNAs, TFs, and miRNA-regulated genes. Our690 iScience 21, 681–694, November 22, 2019
computational model builds on a previously published approach for constructing miRNA regulatory net-
works (Gosline et al., 2016) and integrates chromatin state and expression data to build a multi-layer
network. Our approach differs in a few key aspects from published methodologies. First, it incorporates
predictions from both CLIP-seq data and TargetScan into a combined score that is assigned to network
edges. In addition, our scoring system focuses on a set of miRNAs identified experimentally and weighs
the number of miRNAs contributing to each path, accounting for potential synergistic effects of miRNAs
on downstream gene expression changes. As such, the algorithm presented here can be applied to other
cellular contexts with matchingmiRNA/mRNA/chromatin data and provides a useful framework for the pre-
diction of miRNA effects.
We found that islet cell-enriched miRNAs Let-7g, Let-7a, miR-200a, miR-375, and miR-127 repress different
transcripts involved in cell cycle regulation and thereforemight synergize in driving cell cycle exit and endo-
crine cell differentiation. All four miRNAs have been implicated in the regulation of cell proliferation in
other contexts. Like the Let-7 family miRNAs studied here, Let-7b inhibits proliferation and induces neural
differentiation when over-expressed in neural progenitors (Zhao et al., 2010). Furthermore, Let-7b, miR-
200a, and miR-375 have been shown to induce cell cycle arrest in tumor cells (Liu et al., 2012; Uhlmann
et al., 2010; Wang et al., 2011). Likewise, acute over-expression of miR-375 in dedifferentiated beta cells
reduces their proliferation and promotes their redifferentiation (Nathan et al., 2015). This anti-proliferative
effect of miR-375 is opposite to observations in miR-375-deficient mice, which exhibit decreased beta cell
proliferation (Poy et al., 2009). Since these mice carry a germline mutation ofmiR-375, it is possible that the
observed decrease in beta cell proliferation is the consequence of a developmental defect rather than a
reflection of miR-375 directly regulating inhibitors of cell cycle progression.
Pancreatic endocrine cell differentiation is tightly linked to cell cycle exit. In both mice and humans, endo-
crine cell differentiation depends on the TF NGN3 (encoded by NEUROG3) (Gradwohl et al., 2000;
McGrath et al., 2015), which commits pancreatic progenitors to the endocrine lineage and promotes cell
cycle exit by inducing the cell cycle inhibitors Cdkn1a (p21/CIP1) and Pak3 (Miyatsuka et al., 2011; Piccand
et al., 2014). We observed no effect of either combined or individual Let-7g, Let-7a, miR-200a, and miR-375
over-expression on NEUROG3 mRNA levels (Tables S2A–S2D, S2F), suggesting that these miRNAs exert
their effect on proliferation independent of NGN3. However, Let-7g, Let-7a, miR-200a, and miR-375
expression with the poly-miR construct significantly induced the NGN3 target gene and endocrine differ-
entiation factor NEUROD1 (Ahnfelt-Ronne et al., 2007). Based on our computational model, these miRNAs
are predicted to modulate NEUROD1 expression indirectly through down-regulation of NEUROD1 up-
stream TFs. Given that NEUROD1 can promote cell cycle exit through direct activation of Cdkn1a (Mutoh
et al., 1998), miRNA-mediated modulation of NEUROD1 levels likely contributes to the observed effect of
islet-enriched miRNAs on cell proliferation and differentiation.
Gain- and loss-of-function studies inmodel organisms have shown that the repressive effects ofmiRNAs on their
targets is mostly modest, which has led to the view that miRNAs act to fine-tune gene expression. Consistent
with this view, we observed relatively small effects of miRNA over-expression on gene expression, cell prolifer-
ation, and endocrine cell differentiation. However, these results do notmean that themiRNAs are not important
for endocrine cell differentiation. We over-expressed islet cell-enriched miRNAs in an in vitro system where
growth factor conditions have been optimized for efficient beta cell differentiation. Therefore, the miRNAs
might not be limiting in the context of these optimized conditions. Studies in model organisms underscore
the idea that miRNAs confer robustness to developmental processes and become limiting only under condi-
tions of stress. For example, loss of miR-7 has little effect on Drosophila sensory organ development under
normal conditions, but when environmental stresses are added to the developing organism, miR-7 becomes
necessary (Li et al., 2009). Similar examples exist in worms and mice, where miRNA deletions lead to significant
developmental perturbations only on sensitized backgrounds or under stress (Brenner et al., 2010; Chivukula
et al., 2014). Further illustrating that miRNAs can have significant biological effects in specific contexts, miRNAs
have been shown to drastically augment reprogramming efficiencies (Anokye-Danso et al., 2011; Yoo et al.,
2011). Therefore, the here-identified islet cell-enriched miRNAs could help develop still missing protocols for
robust direct reprogramming of human endocrine cells.Limitations of the Study
One limitation of our approach for identifying endocrine cell differentiation-relevant miRNAs is the focus
on miRNAs that repress mRNAs. There is evidence that miRNAs can activate gene expression or directlyiScience 21, 681–694, November 22, 2019 691
reduce protein levels (El Ouaamari et al., 2008; Jopling et al., 2008; Vasudevan et al., 2007). It is possible
that some of the identified miRNAs regulate endocrine cell differentiation through these mechanisms.
Another limitation is that we compared miRNA profiles in pancreatic progenitors and mature human endo-
crine cells. Therefore, we do not know how these miRNAs are regulated during postnatal endocrine cell
maturation. Finally, our network modeling approach predicts synergist effects of Let-7g, Let-7a, miR-
200a, and miR-375 on cell cycle regulation. This predicted synergy will have to be experimentally validated.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
All RNA-seq and ATAC-seq data generated in this study can be found at GEO with accession number
GSE115327.
Accession numbers for additional data used in this study are as follows: GSE52314 (small RNA-seq, sorted
alpha and beta cells); GSE51924 (CLIP-seq, human islets); E-MTAB-1086 (RNA-seq, PE cells); GSE54471
(H3K27ac, H3K4me3 ChIP-seq, PE cells); GSE51311, E-MTAB-1919, E-MTAB-189, and E-MTAB-191
(H3K27ac, H3K4me3 ChIP-seq, human islets).
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Supplemental figures and legends 
Figure S1 
 
 
Figure S1: Pancreatic endoderm differentiated from CyT49 hESCs. Related 
to Figure 1. 
(A) Schematic of the hESC-based differentiation strategy. (B) 
Immunofluorescence staining of PE cell aggregate sections for PE-specific 
markers PDX1 and SOX9. Scale bar, 50 µm. (C) Representative flow cytometry 
analysis at PE stage for PDX1. hESC, human embryonic stem cells; DE, 
definitive endoderm; GT, gut tube; FG posterior foregut; PE, pancreatic 
endoderm; EN, endocrine cell stage. 
 
  
  
Figure S2
 
  
  
Figure S2. Forced expression of individual miRNAs in hESC-derived 
pancreatic progenitor cells. Related to Figure 2.  
(A) Immunofluorescence staining of pancreatic endoderm (PE) differentiated 
from H1 hESCs for PDX1 and SOX9. Scale bar, 50 µm. (B) Representative flow 
cytometry analysis at PE stage for PDX1. (C) Scatter plot showing correlation in 
mRNA expression between PE cells derived from H1 hESCs and CyT49 hESCs. 
(D) Expression of indicated miRNAs in H1-derived PE cells and islets relative to 
CyT49-derived PE cells determined by Taqman qPCR. Data are shown as mean 
± S.E.M. (n = 3 technical replicates). (E) Representative flow cytometry analysis 
for mCherry 48 h (top row) and 6 days (bottom row) after lentiviral transduction 
with miRNA-mCherry constructs. Gating for cell sorting is shown. (F) Relative 
expression of indicated miRNAs determined by Taqman qPCR in H1 PE cells 48 
h after lentiviral transduction with miRNAs or vector control (C). Data are shown 
as mean ± S.E.M. (n = 3 biological replicates). **P < 0.01, ***P < 0.001; Student’s 
t-test. (G) GSEA plots showing enrichment of genes repressed by Let-7g, Let-7a, 
miR-200a, miR-375, and miR-127 in islets (n = 3) compared to PE (n = 2). False 
Discovery Rate (FDR) is shown.  
 
  
  
Figure S3
 
 
Figure S3. Forced expression of a polycistronic construct for four miRNAs 
in hESC-derived pancreatic progenitor cells. Related to Figure 3. 
(A) Representative flow cytometry analysis for mCherry 48 h (left) and 6 days 
(right) after lentiviral transduction with poly-miR-mCherry construct. Gating for 
cell sorting is shown. (B) Relative expression of indicated miRNAs determined by 
Taqman qPCR in H1 PE cells 48 h after lentiviral transduction with a vector 
control or a polycistronic construct containing Let-7g, Let-7a, miR-200a, and miR-
375 (poly-miR). Data are shown as mean ± S.E.M. (n = 3 biological replicates). 
**P < 0.01, ***P < 0.001; Student’s t-test. (C) GSEA plot showing enrichment of 
genes repressed by the poly-miR construct in islets compared to PE. False 
Discovery Rate (FDR) is shown. (D) Venn diagram showing the overlap between 
genes down-regulated in islets compared to PE (blue) and genes repressed by 
the poly-miR construct (grey). Top five GO categories enriched among genes 
repressed by the poly-miR construct and down-regulated in islets compared to 
PE are shown on the bottom.  
 
  
Figure S4 
 
  
  
Figure S4. Approach to identify core network of miRNA-regulated genes in 
pancreatic progenitor cells. Related to Figure 4. 
(A,B) Schematic of approach to identify core network of miRNA-regulated 
transcription factors and cell cycle genes. Building of network (A) and probing of 
network (B) is shown. The nodes of the graph represent miRNAs [squares; Let-
7g (purple), Let-7a (red), miR-200a (yellow), and miR-375 (green)], transcription 
factors (triangles), transcription factor binding regions (hexagons) and genes 
(circles). In (A), the source for each node is indicated on the left, while evidence 
(indicated by a, b, and c) used to calculate scores is indicated on the right. In (B), 
path-based scoring of an individual gene [e.g. gene 1 (G1)] is shown. See 
Materials and Methods for details. (C) Top five GO categories enriched in genes 
comprising the miRNA-regulated core network in (A). TF, transcription factor; G, 
gene; S, score. 
 
  
  
Figure S5 
 
 
Figure S5. Endocrine cell differentiation from H1 hESCs. Related to Figure 5. 
(A) Representative images showing immunofluorescence staining for insulin 
(INS), Ki-67, mCherry, and DAPI at the endocrine cell (EN) stage for control 
vector (top) or poly-miR (bottom) transduced aggregates. (B) 
Immunofluorescence staining of sections from EN stage aggregates for insulin 
(INS), glucagon (GCG), and somatostatin (SST). Scale bar, 50 µm. 
  
  
Transparent Methods 
 
Contact for reagent and resource sharing 
Further information and requests for reagents may be directed and will be fulfilled 
by the corresponding author Maike Sander (masander@ucsd.edu). 
 
Experimental model and subject details 
Human islets 
Human cadaveric pancreatic islets for the Taqman miRNA analysis (Donor ID:1-
3) and for the RNA-seq and ATAC-seq analysis (Donor ID: 4-7) were obtained 
through the Integrated Islet Distribution Program (IIDP). The islets had ≥ 90% 
purity and ≥ 90% viability. Upon receipt, islets were handpicked and immediately 
processed for RNA extraction or isolation of nuclei.  
Donor 
ID 
Donor 
Age 
Donor 
Sex 
Dia-
betes* BMI Race 
Cause of 
Death 
1 53 Male No 27.2 Caucasian 
CVA/STRO-
KE 
2 48 Female No 31.0 
American 
Indian or 
Alaska Native 
CVA/STRO-
KE 
3 48 Male No 27.7 Caucasian CVA/STROKE 
4 55 Male No 29.8 
Black or 
African 
American 
CVA/STRO-
KE 
5 59 Female No 24.7 Caucasian CNS tumor 
6 55 Male No 23.2 Caucasian Head trauma 
7 56 Female No 33.4 
Black or 
African 
American 
CVA/STRO-
KE 
 
  
*Diabetes status was defined by the patient’s medical record and, when 
available, hemoglobin A1c levels. 
 
Maintenance and differentiation of H1 hESCs 
hESC research was approved by the University of California, San Diego, 
Institutional Review Board and Embryonic Stem Cell Research Oversight 
Committee. All hESC experiments were performed in H1 hESCs with the 
exception of miRNA expression profiling, for which CyT49 hESCs were used.  
H1 hESCs were maintained and differentiated as described with some 
modifications (Rezania et al., 2014). In brief, hESCs were cultured in mTeSR1 
media (Stem Cell Technologies) and propagated by passaging cells every 3 to 4 
days using Accutase (eBioscience) for enzymatic cell dissociation. For 
differentiation of H1 cells, we employed a 2D monolayer culture format up to day 
11 of differentiation. Cells were then dissociated using accutase for 10 min, 
reaggregated by plating the cells in a low attachment 6-well plate on an orbital 
shaker (100 rpm) in a 37 °C incubator. Cells were subsequently cultured in 
suspension from Days 11-14.  
On Day 0, dissociated hESCs were resuspended in mTeSR1 media (see 
media compositions below) and seeded onto Matrigel-coated 12-well plates by 
adding 1 ml of cell suspension (~8 x 105 cells/well) to each well. The following 
day, undifferentiated cells were washed in stage 1 medium and then 
differentiated using a multi-step protocol with stage-specific media (see below) 
and daily media changes.  
  
All stage-specific base media were comprised of MCDB 131 medium (Thermo 
Fisher Scientific) supplemented with NaHCO3, GlutaMAX, D-Glucose, and BSA 
using the following concentrations: 
Stage 1/2 medium: MCDB 131 medium, 1.5 g/L NaHCO3, 1X GlutaMAX, 10 mM 
D-Glucose, 0.5% BSA 
Stage 3/4 medium: MCDB 131 medium, 2.5 g/L NaHCO3, 1X GlutaMAX, 10 mM 
D-glucose, 2% BSA 
Stage 5 medium: MCDB 131 medium, 1.5 g/L NaHCO3, 1X GlutaMAX, 20 mM 
D-glucose, 2% BSA 
 
Media compositions for each stage were as follows: 
Stage 1 (Days 0-2): base medium, 100 ng/ml Activin A, 25 ng/ml Wnt3a (Day 0). 
Day 1-2: base medium, 100 ng/ml Activin A 
Stage 2 (Days 3-5): base medium, 0.25 mM L-Ascorbic Acid (Vitamin C), 50 
ng/mL FGF7 
Stage 3 (Days 6-7): base medium, 0.25 mM L-Ascorbic Acid, 50 ng/mL FGF7, 
0.25 µM SANT-1, 1 µM Retinoic Acid, 100 nM LDN193189, 1:200 ITS-X, 200 nM 
TPB 
Stage 4 (Days 8-10): base medium, 0.25 mM L-Ascorbic Acid, 2 ng/mL FGF7, 
0.25 µM SANT-1, 0.1 µM Retinoic Acid, 200 nM LDN193189, 1:200 ITS-X, 
100nM TPB 
  
Stage 5 (Days 11-14): base medium, 0.25 µM SANT-1, 0.05 µM Retinoic Acid, 
100 nM LDN193189, 1:200 ITS-X, 1 µM T3, 10 µM ALK5 inhibitor II, 10 µM 
ZnSO4, and 10 µg/mL Heparin, 10 µM ROCK inhibitor 
End of stage 1 = definitive endoderm 
End of stage 2 = gut tube 
End of stage 3 = posterior foregut 
End of stage 4 = pancreatic endoderm 
End of stage 5 = endocrine cells 
 
Maintenance and differentiation of CyT49 hESCs 
CyT49 hESCs were maintained and differentiated as described (Xie et al., 2013). 
Propagation of CyT49 hESCs was carried out by passing cells every 3 to 4 days 
using Accutase™ (eBioscience) for enzymatic cell dissociation, and with 10% 
(v/v) human AB serum (Valley Biomedical) included in the hESC medium the day 
of passage. hESCs were seeded into tissue culture flasks at a density of 50,000 
cells/cm2.  
CyT49 hESC medium was comprised of DMEM/F12 (Corning; 45000-346) 
supplemented with 10% (v/v) KnockOut™ Serum Replacement (Thermo Fisher 
Scientific), 1X MEM non-essential amino acids (Thermo Fisher Scientific), 1X 
GlutaMAX™ (Thermo Fisher Scientific), 1% (v/v) penicillin-streptomycin (Thermo 
Fisher Scientific), 0.1mM 2-mercaptoethanol (Thermo Fisher Scientific), 10ng/mL 
Activin A (R&D Systems), and 10ng/mL Heregulin-β1 (PeproTech).  
  
Pancreatic differentiation of CyT49 hESCs was performed as previously 
described (Schulz et al., 2012). Briefly, we employed a suspension-based format 
using rotational culture. Undifferentiated hESCs were aggregated by preparing a 
single-cell suspension in hESC media at 1 × 106 cells/mL and overnight culture in 
six-well ultra-low attachment plates (Costar) with 5.5ml per well on an orbital 
rotator (Innova2000, New Brunswick Scientific) at 95 rpm. The following day, 
undifferentiated aggregates were washed in RPMI media (Corning) and then 
differentiated using a multistep protocol with daily media changes and continued 
orbital rotation at either 95 rpm or at 105 rpm on Days 4 to 8.  
 
Stage 1/2 medium: RPMI medium (Corning), 0.2 % (vol/vol) FBS, 1X GlutaMAX 
Stage 3/4 medium: DMEM High Glucose medium (HyClone), 0.5X B-27 
Supplement, 1X GlutaMAX 
 
Media compositions for each stage were as follows: 
Stage 1 (Days 0-1): Day 0: RPMI/FBS, 100ng/mL Activin A, 50ng/mL mouse 
Wnt3a, 1:5000 ITS. Day 1: RPMI/FBS, 100 ng/mL Activin A, 1:5000 ITS 
Stage 2 (Days 2-4): Day 2: RPMI/FBS, 2.5µM TGF R1 kinase inhibitor IV, 
25ng/mL KGF, 1:1000 ITS. Days 3-4: RPMI/FBS, 25ng/mL KGF, 1:1000 ITS 
Stage 3 (Days 5 -7): DMEM/B27, 3nM TTNPB, 0.25mM KAAD-Cyclopamine, 
50ng/mL Noggin  
Stage 4 (Days 7-10): DMEM/B27, 50ng/mL KGF, 50ng/mL EGF 
 
  
End of stage 1 = definitive endoderm 
End of stage 2 = gut tube 
End of stage 3 = posterior foregut 
End of stage 4 = pancreatic endoderm 
 
Cell line 
HEK293T cells were maintained in DMEM containing 100 units/mL penicillin and 
100 mg/mL streptomycin sulfate supplemented with 10% fetal bovine serum 
(FBS). 
 
Method details 
Immunocytochemistry 
Cells were washed twice before fixation with 4% paraformaldehyde in PBS for 
either 30 min at room temperature, or overnight at 4°C. Cells were then washed 
three times with PBS and incubated in 30% sucrose at 4°C overnight before 
mounting in Optimal Cutting Temperature Compound (Tissue-Tek) and 
sectioning at 10 µm. Immunocytochemistry was performed as described (Xie et 
al., 2013). The following primary antibodies and dilutions were used: guinea pig 
anti-PDX1 (gift from Dr. Christopher Wright, Vanderbilt University) 1:1000; rabbit 
anti-SOX9 (Millipore, AB5535) 1:1000; rabbit anti-Ki-67 (ThermoFisher, RM-
9106-S1) 1:200; guinea pig anti-insulin (LINCO, 4011-01) 1:1000. Secondary 
antibodies were Cy5-, Cy3-, or Alex488-conjugated donkey antibodies against 
guinea pig or rabbit (Jackson Immuno Research Laboratories). Images were 
  
acquired on a Zeiss Axio-Observer-Z1 microscope with a Zeiss AxioCam digital 
camera and figures prepared with Adobe Photoshop CS6/Illustrator CS5.  
To determine the percentage of Ki-67+ cells in the mCherry+ cell 
population, at least ten sections from different aggregates were analyzed per 
hPSC differentiation. For each condition, three independent hPSC differentiations 
were performed. Ki-67+ and mCherry+ cells were quantified using HALO software 
(PerkinElmer Inc).  
 
Fluorescence-activated cell sorting and intracellular flow cytometry 
hESC-derived PE cells were dissociated to a single-cell suspension with 
Accutase (Stemcell Technologies) at 37°C for 10 min. Accutase was neutralized 
with FACS sorting buffer [1% (wt/vol) FBS, 1 mM EDTA, 25mM Hepes, PBS]. 
FACS was performed on a FACS Fortessa equipped with FACS DiVa software 
(BD Biosciences). Cells were sorted into Trizol for RNA analysis. For intracellular 
flow cytometry, dissociated cells were fixed, permeabilized with BD 
Cytoperm/Cytofix (BD Bioscience), and stained with anti-PDX1-PE conjugated 
antibody (BD Biosciences, 562161; 1:20) at room temperature for 30 min, 
washed, and resuspended in FACS buffer. Flow cytometry analysis was 
performed on FACSCanto II (BD Biosciences) and analyzed with FlowJo 
software (FlowJo LLC).  
 
 
 
  
TaqMan microRNA assay  
qRT-PCR for miRNAs was performed using the TaqMan MicroRNA Reverse 
Transcription Kit (Applied Biosystems, Cat. No. 4366596). Briefly, 10 ng of total 
RNA was reverse transcribed using RT primers from the TaqMan MicroRNA 
Assay kit [Applied Biosystems; probe catalogue numbers: Let-7a (000377), Let-
7g (002282), miR-127 (000452), miR-200a (000502), miR-375 (000564), miR-7 
(000268), miR-99b (000436), and RUN44 (001094). qRT-PCR was performed on 
a Bio-rad CFX96 real-time system using the TaqMan Universal PCR Master Mix 
(Applied Biosystems, Cat. No. 4324018) and TaqMan probes from the TaqMan 
MicroRNA Assay kit. miRNA levels were determined on three independent 
samples and values were normalized to endogenous snoRNA RNU44. 
 
miRNA expression vector construction 
To generate miRNA expression vectors, 270 nt of the miRNA gene primary 
transcript, including the 22 nt mature miRNA and 125 nt of genomic sequence 
flanking each side of the miRNA (Chen et al., 2004), were amplified. Let-7a and 
Let-7g were expressed with mutations in their loop sequence to block LIN28 
binding and ensure proper miRNA processing (Piskounova et al., 2008). For 
transduction of PE cells, a modified version of pLKO.3G was used, in which GFP 
was exchanged for mCherry (pLKO.mcherry). For the polycistronic miRNA 
expression vector, a gBlock gene fragment encompassing miR-375, Let-7a, Let-
7g, and miR-200a was cloned into pLKO.mcherry. 
 
  
Lentivirus production and transduction of PE cells 
High-titer lentiviral supernatants were generated by co-transfection of the miRNA 
expression vector and the lentiviral packaging construct into HEK293T cells as 
described (Xie et al., 2013). Briefly, miRNA expression vectors were 
cotransfected with the pCMV-R8.74 (Addgene, #22036) and pMD2.G (Addgene, 
#12259) expression plasmids into HEK293T cells using a 1mg/ml PEI solution 
(Polysciences). Lentiviral supernatants were collected at 48 hr and 72 hr after 
transfection. Lentiviruses were concentrated by ultracentrifugation for 120 min at 
19,500 rpm using a Beckman SW28 ultracentrifuge rotor at 4°C. The titer 
routinely achieved was 5*108~109 TU/ml. For PE cell transductions, H1 hESCs 
were differentiated to the PE stage (Day 8 of differentiation) in monolayer 
cultures and transduced with lentivirus at a MOI of 2. For RNA analysis, cells 
were collected 48 hr after transduction.  
 
Small RNA sequencing and data analysis 
Small RNA-seq data from sorted human alpha and beta cells have been 
described (Kameswaran et al., 2014). RNA from PE stage CyT49 hESC cultures 
was isolated using the miRVana miRNA Isolation kit (Thermo Fisher Scientific). 3 
μg of RNA was used for library preparation using the TruSeq Small RNA sample 
preparation kit (Illumina) and a Pippin Prep (Sage Science) for size selection with 
a 3% cassette (CSD3010). RNA was prepared for sequencing using the Illumina 
protocol (Illumina FC-102-1009) and amplified libraries were sequenced on an 
Illumina Genome Analyzer II (Illumina FC-104-1003). Sequenced libraries were 
  
processed as described (Kameswaran et al., 2014). miRNAs with sample values 
below 1 RPM were excluded from the analysis. There was one replicate each for 
hESC-derived PE, alpha, and beta cells. Each miRNA expression value was log2-
transformed and displayed in a heatmap.  
 
RNA sequencing, mapping and data analysis  
RNA quality was assessed using TapeStation (Agilent Technologies). Libraries 
were prepared according to the instructions of Illumina’s TruSeq RNA library prep 
kit. Libraries were quantified using High Sensitivity DNA screen tape (Agilent 
Technologies) and Qubit dsDNA High Sensitivity (Life Technologies) assays. 
Finally, libraries were multiplexed and sequenced on a HiSeq 2500 (Illumina) 
sequencer using single-end sequencing.  
RNA-seq samples were mapped to the UCSC human transcriptome 
(hg19/GRCh37) by the Spliced Transcripts Alignment to a Reference (STAR) 
aligner (STAR-STAR_2.4.0f1), allowing for up to 10 mismatches (Dobin et al., 
2013). Only reads aligned uniquely to one genomic location were retained for 
subsequent analysis. Expression levels of all genes were quantified by Cufflink 
(https://github.com/cole-trapnell-lab/cufflinks) using only reads with exact 
matches. Genes with average RPKM above 1 were retained for further analyses. 
Differentially expressed genes were identified using a permutation test, 
with the number of permutations set to 1000. Briefly, all the samples were 
shuffled, fold changes were computed to obtain a null distribution, and a P-value 
was estimated for each gene's fold change as a cumulative probability from the 
  
null distribution. For comparison of PE and islet data and poly-miR versus control 
data at the EN stage, batch effects were removed using ComBat (Johnson et al., 
2007).  
 
Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) analysis 
We applied GSEA (http://www.broad.mit.edu/gsea), which scores a-priori defined 
gene sets in two different conditions (Subramanian et al., 2005). GSEA 
(http://www.broad.mit.edu/gsea) was run with the number of permutations for P-
value computation set to 1000. We used genes significantly repressed by 
miRNAs (P < 0.05, permutation test) as gene sets to determine coordinated 
regulation in islets compared to PE samples. Gene sets with a false discovery 
rate of < 0.05 were considered significantly enriched. Enrichment of gene sets for 
Gene Ontology (GO) terms was tested using Metascape (Tripathi et al., 2015).  
 
ATAC-seq sample preparation 
Roughly 50,000 PE or primary human islet cells were used for each ATAC-seq 
assay as described (Buenrostro et al., 2013). Briefly, cell nuclei were isolated 
using cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 
0.1% IGEPAL CA-630). The nuclei pellet was resuspended in the transposase 
reaction mix; 25 μL 2x TD buffer, 2.5 μL transposase (Illumina) and 22.5 μL 
nuclease-free water at 37°C for 30 min. Then transposed DNA fragments were 
purified using the Qiagen MinElute kit and amplified 10-12 cycles using the 
  
Nextera (Illumina) PCR primers. Libraries were sequenced on HiSeq4000 
platform. 
 
ChIP-seq and ATAC-seq data analysis 
ChIP-seq and ATAC-seq reads were mapped to the human genome 
(hg19/GRCh37) using Bowtie (Langmead et al., 2009) and BWA (Li and Durbin, 
2009), respectively, and visualized using the UCSC Genome Browser (Kent et 
al., 2002). Unmapped reads were discarded. After mapping, SAMtools (Li et al., 
2009) was used to remove duplicate sequences and merge samples. Here, 
“SAMtools view -Sbq 30” was used to filter out reads with mapping quality less 
than 30, "SAMtools rmdup” was used to remove duplicated reads, and "SAMtools 
merge” was used to merge files of the same histone marker or input condition. 
ChIP-seq and ATAC-seq analysis was performed in two biological replicates for 
PE and 4-5 donors for islet. The Pearson correlation among biological replicates 
ranged from 64% to 96% for human islets and 91% to 96% for PE.  
HOMER (Heinz et al., 2010) as used to call ChIP-seq peaks using 
“findPeaks function” with “–style histone” to call peaks. Stage- and condition-
matched input DNA controls were used as background when calling peaks. 
MACS2 (Zhang et al., 2008) was used to call peaks from ATAC-seq data, with 
parameters “shift set to 100 bps, smoothing window of 200 bps” and with 
“nolambda” and “nomodel” flags on. 
To link changes in chromatin to gene expression changes, we first defined 
differential H3K27ac and H3K4me3 peaks in PE and islet (adjusted P<0.05, 
  
“getDifferentialPeaksReplicates” function in HOMER) and then used BEDtools 
(Quinlan and Hall, 2010) to identify overlapping ATAC peaks in PE or islet using 
a ± 1.5 kb window from the summit of the ATAC peak. Next, we identified the 
nearest TSS within a 10kb window of the H3K27ac or H3K4me3 peak. We then 
assessed the concordance of the directionality of changes in gene expression 
and histone marks by evaluating whether genes near regions showing gain or 
loss of H3K27ac or H3K4me3 in PE versus islet exhibit significant concordant 
expression changes (Mann-Whitney test).  
 
Network building  
CLIP-seq signal, mRNA expression, ATAC-seq and ChIP-seq binding data were 
encoded in a graphical model depicted in Figures 4 and Figure S4 by adapting a 
previously published algorithm (Gosline et al., 2016). Nodes arranged in four 
different layers, corresponding to miRNAs, transcription factors (TFs), DNA 
regions, and genes, were identified and connected as follows: For each of the 
four selected miRNAs, predicted target genes were retrieved through the 
TargetScan repository (http://www.targetscan.org/vert_71/). For the pairs of 
miRNA-target gene identified, the corresponding CLIP-seq signal was collected 
from previously published data (Kameswaran et al., 2014). Among the targets, 
TFs in the second layer of the network were selected based on down-regulation 
by poly-miR transfection compared to control with P < 0.05 and with an 
annotation in the TF Animal Database (Zhang et al., 2015). In the third layer of 
the network, we selected DNA regions showing significant changes in PE versus 
  
islet for H3K27ac or H3K4me3 (see previous paragraph) with the nearest gene 
showing down-regulation by poly-miR transfection, hereafter referred to as Rsel. 
The Rsel DNA regions were filtered for links to the selected TFs by scoring the 
match of their binding motifs with the DNA regions in the network. Briefly, motifs 
of selected TFs were extracted from a collection of databases, including JASPAR 
(http://jaspar.genereg.net/cgi-bin/jaspar_db.pl), Hocomoco 
(http://hocomoco11.autosome.ru/), and ENCODE-related data sets (Aylward et 
al., 2018) and scored for matches with narrow regions spanning 300bp around 
the peak summits of each Rsel. Log-odds scores and corresponding P-values 
were obtained using the MEME Suite tool FIMO (http://meme-
suite.org/tools/fimo) with default parameters. The last layer was defined by 
considering genes proximal to DNA regions, as described above, and filtering for 
those differentially regulated in poly-miR versus control (P < 0.05). 
A score representing the strength of the association was computed for 
each pair of connected nodes in the different network layers, as follows: Given 
the TargetScan context++ score 𝑆𝑖  (Agarwal et al., 2015) and the CLIP-seq 
signal 𝑆𝑗 of each miRNA-TF association, their values were normalized in a 0-1 
range and combined as𝑎 = (1 − 𝑆𝑖)(1 − 𝑆𝑗) (Szklarczyk et al., 2015). Scores of 
edges connecting TFs to Rsel regions were defined as the𝑏 = 1 − 𝑞, 𝑞 being the 
q-value returned by FIMO, representing the probability of obtaining the log-odds 
ratio scores of the matches by chance. Scores from DNA regions to genes were 
defined as the absolute value of the Log2 Fold Change of each gene 𝑥in poly-
miR versus control data: 𝑐 = |𝐿𝑜𝑔2𝐹𝐶(𝑥)|A combined score was computed for 
  
each possible path in the network starting from a miRNA to a gene, by adding the 
contribution of the different layers, as: 𝑆 = 𝑎 + 𝑏 + 𝑐. 
 
Network-based gene ranking  
Given an individual gene, G1, all network paths connecting a miRNA to G1 were 
considered with their corresponding scores and compared for gene ranking as 
follows: Among the paths connecting the same miRNA to G1, only the one with 
the highest score was retained, obtaining a score Si for each of the k miRNAs 
showing an indirect link to G1, k<=N, with N equal to the number of miRNAs in 
the network (N=4). A first score summarizing the strength of the association of 
these retrieved network paths was computed as 𝑆𝑛𝑒𝑡(𝐺1) = 𝑚𝑒𝑎𝑛(𝑆𝑖), i ranging 
from one to k. A second score, accounting for the synergistic effect of several 
miRNAs on the same gene, was computed as proportion of miRNAs in at least 
one network path linking to the selected gene G1: 𝑆𝑚𝑖𝑟(𝐺1) = 𝑘 𝑁⁄ . Finally, a 
combined score for G1 was obtained as a weighted sum of 𝑆𝑛𝑒𝑡and 𝑆𝑚𝑖𝑟 , i.e. 
𝑆𝑐𝑜𝑚𝑏(𝐺1) = 𝑤 ∗ 𝑆𝑛𝑒𝑡(𝐺1) + 𝑤 ∗ 𝑆𝑚𝑖𝑟(𝐺1), with w set to 0.5. This procedure was 
applied to score individual genes annotated to cell cycle regulation in the Gene 
Ontology (GO:0051726) and genes were ranked based on 𝑆𝑐𝑜𝑚𝑏values. 
 
Quantification and statistical analysis 
Statistical parameters including FDR, R, and P-values are reported in the Figures 
and the Figure Legends. 
 
  
KEY RESOURCES TABLE 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit anti-PDX1 Abcam Cat# ab47267, 
RRID:AB_777179 
Rabbit anti-SOX9 Millipore Cat# AB5535, 
RRID:AB_2239761 
Guinea pig anti-INS Dako Cat# A0564, 
RRID:AB_10013624 
Mouse anti-GCG Sigma-Aldrich Cat# G2654, 
RRID:AB_259852 
Rabbit anti-SST Agilent Cat# A056601-2 
Mouse anti-Ki67 Lab Vision Cat# RM-9106-S1, 
RRID:AB_149792 
Mouse anti-PDX1, PE conjugate BD Biosciences Cat# 562161, 
RRID:AB_10893589 
Mouse IgG1, kappa isotype control (PE conjugate) BD Biosciences Cat# 556650, 
RRID:AB_396514 
Chemicals, Peptides, and Recombinant Proteins 
DPBS Corning Cat# 45000-434 
Fatty Acid-Free BSA Proliant Biologicals Cat# 68700 
D-(+)-Glucose Solution, 45% Sigma-Aldrich Cat# G8769 
Accutase® eBioscience Cat# 00-4555-56 
Penicillin-Streptomycin Thermo Fisher 
Scientific 
Cat# 15140122 
GlutaMAX™ Thermo Fisher 
Scientific 
Cat# 35050061 
MEM Non-Essential Amino Acids Solution (100X) Thermo Fisher 
Scientific 
Cat# 11140050 
Sodium Bicarbonate Sigma-Aldrich Cat# NC0564699 
Matrigel® Corning Cat# 356231 
ROCK Inhibitor Y-27632 STEMCELL 
Technologies 
Cat# 72305 
mTeSR1 Complete Kit - GMP STEMCELL 
Technologies 
Cat# 85850 
RPMI 1640 1X, w/o L-Glutamine Corning Cat# 45000-404 
DMEM/F12 with L-Glutamine, HEPES Corning Cat# 45000-350 
DMEM/F12 w/o L-Glutamine Corning Cat# 45000-346 
HyClone Dulbecco’s Modified Eagles Medium Thermo Fisher 
Scientific 
Cat# SH30081.FS 
MCDB 131 Thermo Fisher 
Scientific 
Cat# 10372-019 
CTS™ KnockOut™ SR XenoFree Kit Thermo Fisher 
Scientific 
Cat# A1099202 
Insulin-Transferrin-Selenium (ITS-G) (100X) Thermo Fisher 
Scientific 
Cat# 41400045 
Insulin-Transferrin-Selenium-Ethanolamine (ITS-X) 
(100X) 
Thermo Fisher 
Scientific 
Cat# 51500-056 
B-27™ Supplement (50X) Thermo Fisher 
Scientific 
Cat# 17504044 
 Bovine Albumin Fraction V (7.5%) Thermo Fisher 
Scientific 
Cat# 15260037 
2-Mercaptoethanol Thermo Fisher 
Scientific 
Cat# 21985-023 
Human AB Serum Valley Biomedical Cat# HP1022 
Activin A R&D Systems Cat# 338-AC/CF 
Heregulin-1 Peprotech Cat# 100-03 
ALK5 Inhibitor II Enzo Life Sciences Cat# ALX-270-445 
KGF/FGF7 R&D Systems Cat# 251-KG 
EGF R&D Systems Cat# 236-EG 
Retinoic Acid Sigma-Aldrich Cat# R2625 
LDN-193189 Stemgent Cat# 04-0074 
SANT-1 Sigma-Aldrich Cat# S4572 
TPB Calbiochem Cat# 565740 
Noggin R&D Systems Cat# 3344-NG-050 
Wnt3a R&D Systems Cat# 1324-WN-010 
3,3’,5-Triiodo-L-thyronine sodium salt (T3) Sigma-Aldrich Cat# T6397 
TGF R1 kinase inhibitor IV EMD Biosciences Cat# 616454 
KAAD-Cyclopamine Toronto Research 
Chemicals 
Cat# K171000 
Heparin Sigma-Aldrich Cat# H3149 
TTNPB Sigma-Aldrich Cat# T3757 
Zinc Sulfate Sigma-Aldrich Cat# Z0251 
TRIzol® Thermo Fisher 
Scientific 
Cat# 15596018 
Polyethylenimine (PEI) Polysciences Cat# 23966-1 
O.C.T. Compound Sakura Finetek USA Cat# 25608-930 
Vectashield Antifade Mounting Medium Vector Laboratories Cat# H-1000 
Critical Commercial Assays 
MinElute Reaction Cleanup Kit QIAGEN Cat#28204 
miRNeasy Mini Kit QIAGEN Cat# 74104 
mirVana™ miRNA Isolation Kit Thermo Fisher 
Scientific 
Cat# AM1560 
Nextera DNA Library Preparation Kit (24 samples) Illumina Cat#FC-121-1030 
TruSeq Stranded mRNA Library Preparation Kit Illumina Cat# 20020594 
TruSeq Small RNA Library Preparation Kit Illumina Cat# RS-200-0012 
RNA 6000 Nano Kit Agilent Technologies Cat# 5067-1511 
High Sensitivity D1000 ScreenTape Agilent Technologies Cat# 5067-5584 
RNA ScreenTape Agilent Technologies Cat# 5067-5576 
RNA ScreenTape Sample Buffer Agilent Technologies Cat# 5067-5577 
RNA ScreenTape Ladder Agilent Technologies Cat# 5067- 5578 
Qubit ssDNA assay kit Thermo Fisher Scientific Cat# Q10212 
iScript™ cDNA Synthesis Kit Bio-Rad Cat# 1708890 
iQ™ SYBR® Green Supermix Bio-Rad Cat# 1708880 
Cytofix/Cytoperm W/Golgi Stop Kit BD Biosciences Cat# 554715 
 Deposited Data 
RNA-seq and ATAC-seq data GEO GSE115327 
Experimental Models: Cell Lines 
H1 WiCell Research 
Institute 
NIHhESC-10-0043, 
RRID:CVCL_9771 
CyT49 ViaCyte, Inc. NIHhESC-10-0041, 
RRID:CVCL_B850 
HEK293T ATCC Cat# CRL-3216, 
RRID:CVCL_0063 
Oligonucleotides 
 
Assay ID: 000377, Taqman miRNA assay; hsa-let-7a 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 002282, Taqman miRNA assay; hsa-let-7g 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000452, Taqman miRNA assay; hsa-
mIR127- 3p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000502, Taqman miRNA assay; hsa-
mIR- 200a-3p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 002300, Taqman miRNA assay; hsa-
mIR- 200c-3p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000377, Taqman miRNA assay; hsa-let-7a 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000564, Taqman miRNA assay; hsa-mIR-375 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000268, Taqman miRNA assay; hsa-mIR-
7- 5p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 000436, Taqman miRNA assay; hsa-
mIR- 99b-5p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
Assay ID: 001182, Taqman miRNA assay; hsa-
mIR- 124-3p 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 
Assay ID: 001094, Taqman miRNA assay; RNU control 
Thermo Fisher 
Scientific 
 
Cat# 4427975 
 ATTTgaattctcagccgcagatgcgttcaggtgagggcggaggctagcg 
gggcgctgtgcagcactgagctcgcggaagaccaggaccaggagatca
c 
cgagggcgaccgccaggccccgggccctccgctcccgccccgcgacga 
gcccctcgcacaaaccggacctgagcgttttgttcgttcggctcgcgtgagg 
caggggcggcctctcagcaccagcccgggggccggcctgatcgccacgc 
aggcacctgccgccgccaccgccaccgccatctcaaccgtacgggtggg 
agaggctgtgcgccgctccaggggagatccggctcccatccggccccacc 
cgccctgccttgccctgcccgcagcttctTTCTTATCACTCACACA 
GGAAACCAGGATTACCGAGGAGGAAAAAAAGCCTT 
CCTGTGGTGCTCAACTGTGATTCCTTTTCACCATTC 
ACCCTGGATGTTCTCTTCACTGTGGGATGAGgtAGT
A 
GGTTGTATAGTTctgttgaatctcatggACTATACAATCTAC 
TGTCTTTCCTAACGTGATAGAAAAGTCTGCATCCAG 
GCGGTCTGATAGAAAGTCAGTTAACTAATTGTACAA 
TATTTAAGATTAACTTGTCTTAAAGAGATGTAGTGC
A 
GCATTTGTTTATGGCCTGGAAATAAATTAATTTAGA
G 
ATAAAGTCTGTAGCAAGTACACTGGATGGGctccaaat 
gtggtgcaagatgaggcaaatgtgtggcacttgtagctttgctgccaagcctc 
tgctgtgaggatgttccctttcctgtctcaagtgcatcctgaagagttcctccag 
cgctccgtttccttttgcctgattccaggctgaggtagtagtttgtacagttctgtt 
gaatctcatggctgtacaggccactgccttgccaggaacagcgcgccagct 
gccaagtggggctgagaggatggcgtcaccctgctcatctctgggaaacc
a 
ggtaatggggaggaagtcCACCACCCCTGGCTGCTCACCG 
CTCCGGTTCTTCCCTGGGCTTCCACAGCAGCCCCT 
GCCTGCCTGGCGGGACCCCACGTCCCTCCCGGGC 
CCCTGTGAGCATCTTACCGGACAGTGCTGGATTTC
C 
CAGCTTGACTCTAACACTGTCTGGTAACGATGTTCA 
AAGGTGACCCGCCGCTCGCCGGGGACACCACCGA 
GGCACATCCGGAGCTCCTACTCCAGGGATGGGCTG 
TTTTTTttaattaaGGTG 
This study IDT gBlock 
Software and Algorithms 
Flowjo-v10 FlowJo LLC http://www.flowjo.co 
m/download-newest- 
version/ 
STAR 2.4.0f1 (Dobin et al., 2013) https://github.com/al 
exdobin/STAR 
Bowtie 1.1.1 (Langmead et al., 
2009) 
http://bowtie- 
bio.sourceforge.net/i 
ndex.shtml 
Cufflinks 2.2.1 (Trapnell et al., 2010) https://github.com/co 
le-trapnell- 
lab/cufflinks 
HTSeq 0.6.1 (Anders et al., 2015) https://htseq.readthe 
docs.io/en/master/in 
stall.html 
DEseq2 1.10.1 (Love et al., 2014) https://www.biocond 
uctor.org/packages/d 
evel/bioc/html/DESe 
q2.html 
MACS2 (Zhang et al., 2008) http://liulab.dfci.harv 
ard.edu/MACS/Dow 
nload.html 
 BEDTools 2.17.0 (Quinlan and Hall, 
2010) 
https://bedtools.readt 
hedocs.io/en/latest/c 
ontent/installation.ht 
ml 
ComBat (part of the sva Bioconductor package) (Johnson et al., 2007) 
(Leek, 2014) 
http://bioconductor.o 
rg/packages/release/ 
bioc/html/sva.html 
GSEA (Mootha et al., 2003; 
Subramanian et al., 
2005) 
http://www.broad.mit 
.edu/gsea 
Metascape (Tripathi et al., 2015) http://metascape.org 
/gp/index.html#/main 
/step1 
TargetScan (Agarwal et al., 2015) http://www.targetsca 
n.org/vert_72/ 
JASPAR (Khan et al., 2018) http://jaspar.genereg 
.net/cgi- 
bin/jaspar_db.pl 
Hocomoco (Kulakovskiy et al., 
2018) 
http://hocomoco11.a 
utosome.ru/ 
FIMO (Grant et al., 2011) http://meme- 
suite.org/tools/fimo 
R 3.5.0  https://cran.r- 
project.org/ 
SAMtools 1.3 (Li et al., 2009) https://github.com/sa 
mtools/samtools 
HOMER 4.10 (Heinz et al., 2010) http://homer.ucsd.ed 
u/homer/download.ht 
ml 
HALO™ Image Analysis Software PerkinElmer http://www.perkinelm 
er.com/product/halo- 
plus-3-ws-license- 
cls141255 
Adobe Illustrator CS5   
Adobe Photoshop CS5   
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